Abstract wide illustration showing Japan drug pricing from listing to post-launch revisions, using blue shapes on a sand background with red trigger markers.
On December 12, 2025, Japan’s Ministry of Health, Labour and Welfare (MHLW) tabled a draft outline […]
An unusual bio-lab showcasing the transition from traditional to streamlined clinical trial phases in Japan.
Japan is once again demonstrating its commitment to advancing the global pharmaceutical landscape with a groundbreaking […]